Related references
Note: Only part of the references are listed.Safety of liposomal cytarabine CNS prophylaxis in children, adolescent and young adult hematopoietic stem cell transplant recipients with acute leukemia and non-Hodgkin lymphoma
J. Hochberg et al.
BONE MARROW TRANSPLANTATION (2016)
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP
Norbert Schmitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Central Nervous System Involvement in Acute Myeloid Leukemia Patients Undergoing Hematopoietic Cell Transplantation
Merav Bar et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Outcomes of Patients with Acute Lymphoblastic Leukemia (ALL) with Central Nervous System (CNS) Involvement Undergoing Allogeneic Hematopoietic Cell Transplantation (AlloHCT): A Single Center Retrospective Analysis
Monzr M. Al Malki et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults
Chieh-Lung Cheng et al.
BMC CANCER (2015)
High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial
Andres J. M. Ferreri et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology
Khe Hoang-Xuan et al.
LANCET ONCOLOGY (2015)
CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma
Aurelien Viaccoz et al.
NEURO-ONCOLOGY (2015)
Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era
Andres J. M. Ferreri et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
MicroRNAs as Potential Biomarkers for Diagnosing Cancers of Central Nervous System: a Meta-analysis
Dong Wei et al.
MOLECULAR NEUROBIOLOGY (2015)
Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia
Uri Rozovski et al.
LEUKEMIA & LYMPHOMA (2015)
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients with Central Nervous System Involvement
Jun Aoki et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Central Nervous System Relapse in Adults with Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
Amir Hamdi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma
C. Y. Cheah et al.
BRITISH JOURNAL OF CANCER (2014)
Primary CNS Natural Killer/T-Cell Lymphoma of the Nasal Type Presenting in a Woman: Case Report and Review of the Literature
Hasmukh J. Prajapati et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Central nervous system involvement in diffuse large B-cell lymphoma: an analysis of risks and prevention strategies in the post-rituximab era
Christopher D. Fletcher et al.
LEUKEMIA & LYMPHOMA (2014)
The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma
Brian Patrick O'Neill et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma
James L. Rubenstein et al.
BLOOD (2013)
Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement
Richard T. Maziarz et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Current uses of radiation therapy in patients with primary CNS lymphoma
Giovanni Citterio et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2013)
Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas
Agnieszka Korfel et al.
HAEMATOLOGICA (2013)
Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202)
James L. Rubenstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Primary leptomeningeal lymphoma International Primary CNS Lymphoma Collaborative Group report
Jennie W. Taylor et al.
NEUROLOGY (2013)
Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial
A. Korfel et al.
ANNALS OF ONCOLOGY (2012)
Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease
Ferial Shihadeh et al.
CANCER (2012)
MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma
Alexander Baraniskin et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system
Alexander Baraniskin et al.
BLOOD (2011)
Age, gender, and racial differences in incidence and survival in primary CNS lymphoma
J. L. Villano et al.
BRITISH JOURNAL OF CANCER (2011)
Whole-brain radiotherapy in primary CNS lymphoma
Andres J. M. Ferreri et al.
LANCET ONCOLOGY (2011)
RITUXIMAB MONOTHERAPY FOR PATIENTS WITH RECURRENT PRIMARY CNS LYMPHOMA
T. T. Batchelor et al.
NEUROLOGY (2011)
High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma
Marc C. Chamberlain et al.
NEURO-ONCOLOGY (2010)
The Presence of Central Nervous System Disease at Diagnosis in Pediatric Acute Myeloid Leukemia Does Not Affect Survival: A Children's Oncology Group Study
Donna L. Johnston et al.
PEDIATRIC BLOOD & CANCER (2010)
Identification of Leptomeningeal Disease in Aggressive B-Cell Non-Hodgkin's Lymphoma: Improved Sensitivity of Flow Cytometry
Sandra Quijano et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study
Hendrik Pels et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
Andres J. M. Ferreri et al.
LANCET (2009)
Therapeutic challenges in primary CNS lymphoma
Patrick G. Morris et al.
LANCET NEUROLOGY (2009)
Protein biomarker identification in the CSF of patients with CNS lymphoma
Sushmita Roy et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia
Julie E. Chang et al.
LEUKEMIA & LYMPHOMA (2008)
Meningeal dissemination in primary CNS lymphoma -: Prospective evaluation of 282 patients
L. Fischer et al.
NEUROLOGY (2008)
Primary CNS lymphoma with intraocular involvement International PCNSL Collaborative Group Report
S. A. Grimm et al.
NEUROLOGY (2008)
Results of compassionate therapy with intrathecal depot liposomal cytarabine in acute myeloid leukemia meningeosis
Juan-Manuel Sancho et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2007)
Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia
Elias Jabbour et al.
BLOOD (2007)
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma - a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
V. Boehme et al.
ANNALS OF ONCOLOGY (2007)
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993
Hillard M. Lazarus et al.
BLOOD (2006)
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
S de Botton et al.
LEUKEMIA (2006)
Leukemic and lymphomatous meningitis: incidence, prognosis and treatment
MC Chamberlain et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma
LE Abrey et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital
CH Pui et al.
BLOOD (2004)
Primary central nervous system lymphoma: Results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy
H Pels et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Ouality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis
BF Cole et al.
CANCER (2003)
Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: A report of NABTT 96-07
T Batchelor et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Prognostic scoring system for primary CNS lymphomas: The international extranodal lymphoma study group experience
AJM Ferreri et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Intraventricular and intravenous treatment of a patient with refractory primary CNS lymphoma using rituximab
H Pels et al.
JOURNAL OF NEURO-ONCOLOGY (2002)
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01
LB Silverman et al.
BLOOD (2001)
Results of treatment with Hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia
HM Kantarjian et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)